Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
The bone marrow microenvironment as a mediator of chemoresistance in acute lymphoblastic leukemiaLauren K Meyer, Michelle L HermistonCancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
The epigenome in pediatric acute lymphoblastic leukemia: drug resistance and therapeutic opportunitiesLauren K Meyer, Michelle L HermistonHematology/Oncology Clinics of North America|March 25, 2025
Clinical Characteristics and Treatment of Familial Hemophagocytic LymphohistiocytosisLauren K Meyer, Camille Keenan, Kim E NicholsFrontiers in Immunology|March 27, 2023
Insights into the cellular pathophysiology of familial hemophagocytic lymphohistiocytosisErica A Steen, Kim E Nichols, Lauren K MeyerHaematologica|November 3, 2025
Histiocyte Society blueprint for hemophagocytic lymphohistiocytosis research: deciphering underlying disease mechanisms to optimize diagnosis and therapyLauren K Meyer, Jerry C Lee, Joseph M Rocco, et al.Frontiers in Immunology|December 6, 2021
Digenic Inheritance: Evidence and Gaps in Hemophagocytic LymphohistiocytosisErica A Steen, Michelle L Hermiston, Kim E Nichols, et al.Adipocyte|September 21, 2013
Adipose tissue depot and cell size dependency of adiponectin synthesis and secretion in human obesityLauren K Meyer, Theodore P Ciaraldi, Robert R Henry, et al.Hematology/Oncology Clinics of North America|April 8, 2025
Genetics of Familial Hemophagocytic Lymphohistiocytosis (HLH)Kejian Zhang, Lauren K Meyer, Rafal Machowicz, et al.Plos One|July 19, 2019
CRLF2 rearrangement in Ph-like acute lymphoblastic leukemia predicts relative glucocorticoid resistance that is overcome with MEK or Akt inhibitionLauren K Meyer, Cristina Delgado-Martin, Shannon L Maude, et al.Blood Advances|March 10, 2023
Opposing effects of KDM6A and JDP2 on glucocorticoid sensitivity in T-ALLAnya L Levinson, Karensa Tjoa, Benjamin Huang, et al.Pageof 2